Skip to content
RheumaFinder Announces Investment by Novalis Biotech

RheumaFinder Announces Investment by Novalis Biotech

12 February 2024

Februari 2024 – RheumaFinder is excited to announce an investment from Belgium’s Novalis Biotech Acceleration Fund. This investment, executed as…

New offices at the Watt Factory in Ghent

New offices at the Watt Factory in Ghent

16 December 2023

New offices at the Watt Factory in Ghent The RheumaFinder team has moved to new offices at the Watt Factory…

RheumaFinder’s study on validating the diagnostic accuracy of AI detecting hallmark lesions gets published in European Radiology

RheumaFinder’s study on validating the diagnostic accuracy of AI detecting hallmark lesions gets published in European Radiology

26 May 2023

Dr. Thomas Van Den Berghe’s recent study called “Neural network algorithm for detection of erosions and ankylosis on CT of…

Fund for Scientific Research in Rheumatology (FWRO/FRSR)

Fund for Scientific Research in Rheumatology (FWRO/FRSR)

16 September 2022

Fund for Scientific Research in Rheumatology (FWRO/FRSR) Prof. Dr. Lennart Jans of RheumaFinder has been named as a recipient from…

Interview by the leading online newspaper Medscape

Interview by the leading online newspaper Medscape

16 September 2022

Interview by the leading online newspaper Medscape Prof. Dr. Lennart Jans was interviewed by the leading online newspaper Medscape at…

Annual scientific meeting of the European Alliance of Associations for Rheumatology (EULAR) Copenhagen

Annual scientific meeting of the European Alliance of Associations for Rheumatology (EULAR) Copenhagen

16 September 2022

At the annual scientific meeting of the European Alliance of Associations…

European Society of Musculoskeletal Radiology Young Researcher Grant 2022

European Society of Musculoskeletal Radiology Young Researcher Grant 2022

17 August 2022

Very grateful and proud to announce that our Chief Science Officer, Thomas Van Den Berghe…

Back To Top